Image

The Aging Eye Cohort Study

Recruiting
60 - 95 years of age
Both
Phase N/A

Powered by AI

Overview

Aging is a major risk factor for many blind-causing eye diseases, e.g., glaucoma, age-related cataracts, and age-related macular degeneration. With the population aging, the impact of lifestyle changes (less time spent outdoors, increasingly sedentary lifestyles, and unhealthy eating habits) on the eye health of the elderly needs further research. This study focuses on establishing a cohort of elderly subjects with normal vision and ocular structure at baseline. The main goal is to study the risk factors for common eye diseases in Chinese elderly population while providing normal-controlled clinical and genomic data for other clinical studies on eye diseases.

Eligibility

Inclusion criteria:

  1. Be able and willing to consent to the qualification and the follow-up phases of the study;
  2. Be able to undergo yearly examinations for ≥5 years;
  3. Age is older than 60 years;
  4. Best-corrected visual acuity of both eyes is better than 20/32;
  5. Intraocular pressure (non-contact tonometer) is between 10-21 mmHg;
  6. Except for mild cataracts, no other structural abnormalities of the eye are found.
  7. have fundus photographs of adequate quality as assessed with a standardized protocol by the University of Wisconsin Fundus Photograph Reading Center.

Exclusion Criteria:

  1. the presence of ocular disease in either eye, except for mild cataracts and ametropia;
  2. previous retinal or other ocular surgical procedures (other than cataract extraction and capsulotomy);
  3. a chronic requirement for any systemic or ocular medication administered for other diseases and known to be toxic to the retina or optic nerve;
  4. cataract surgery within three months or capsulotomy within six weeks before the qualification visit;
  5. any systemic disease with a poor 5-year survival prognosis.

Study details

Eye Diseases

NCT05851287

Zhongshan Ophthalmic Center, Sun Yat-sen University

26 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.